This symposium will investigate the links between metabolic dysfunction and asthma, highlighting recent developments in clinical, translational and basic research. Topic 1 will review the mechanisms and management of obesity-related asthma. In Topic 2 the speaker will focus on the interplay of type 2 diabetes and asthma. In Topic 3 the speaker will present a novel pathway through the glucagon-like peptide-1 receptor as therapeutic target for asthma with and without metabolic dysfunction.

LEARNING OBJECTIVES:
Upon completion of this activity, participants should be able to:

• Analyze mechanisms underlying associations between metabolic abnormalities and asthma
• Identify the need for new therapeutic approaches for individuals with asthma and metabolic dysfunction

Moderator Introduction
Katherine  N. Cahill, MD
Vanderbilt University Medical Center

Obese Asthotype” or Many?ma: One “End
Anne  E. Dixon, MD
University of Vermont

The GLP-1 Receptor: A Promising Novel Target to Address Airway Inflammation in Lean and Obese Asthma
Stokes Peebles, MD FAAAAI
Vanderbilt Univ School of Medicine

Hyperglycemia, Metformin and Asthma Exacerbations: Unraveling the Diabetes-Asthma Relationship
Meredith  C. McCormack, MD
Johns Hopkins Pulmonary

Please take a moment to click the link below and give us your feedback on this session:  

>>Evaluation